Pharma

The latest meeting of the Committee for Medicinal Products for Human Use (CHMP) has ushered in notable advancements in the pharmaceutical landscape with ten...

In the complex world of mental health treatment, addressing the needs of individuals with treatment-resistant schizophrenia (TRS) poses significant challenges. Despite advancements in antipsychotic...

The rapid growth of digital platforms and non-traditional data sources in the pharmaceutical industry has necessitated an update to the ICH E2D guidelines on...

For patients battling non-small cell lung cancer (NSCLC) with extensive brain metastases (BMs), prognosis often looks grim when treated with radiotherapy alone. The integration...

In a compelling breakthrough for Type 1 diabetes (T1D) treatment, Teizeild, a pharmaceutical innovation from Sanofi Winthrop Industrie, recently received a pivotal endorsement from...

The European Union’s nod to cilofexor marks a significant moment in the medical field, specifically for treating primary sclerosing cholangitis (PSC). As cometitor drugs...

The upcoming 2028 introduction of Part B drugs into Medicare's Drug Price Negotiation Program, shaped by the Inflation Reduction Act (IRA), presents a complex...

In a world where vision becomes compromised with age, Apellis Pharmaceuticals introduces a beacon of hope through its comprehensive data from the GALE extension...

In the race to enhance patient outcomes in stage III non-small cell lung cancer (NSCLC) with EGFR mutations, osimertinib emerges as a compelling solution....

In the heart of Tarrytown, New York, a wave of excitement emanates from Regeneron Pharmaceuticals as the company prepares to unveil significant advancements at...

Advancements in the battle against cancer have ignited fresh interest, especially with promising therapies altering current paradigms. In the complex landscape of lung cancer...

The European Medicines Agency (EMA) has set the stage for a promising advancement in bone disease treatment with a recent endorsement. The Committee for...

Merck takes a strategic leap forward with its recent acquisition of Cidara Therapeutics, a move reflecting both companies' commitment to advancing influenza prevention. By...

In the ongoing battle against HIV, the European market introduced a streamlined treatment option: Juluca. Comprised of two key active substances, dolutegravir and rilpivirine,...

The European Medicines Agency (EMA) has conducted a robust review of the periodic safety update report for the active substances estradiol (17-beta) and progesterone,...